Sequana Medical NV Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	44	136	113	142	140	186
Market Cap Growth	-38.53%	20.36%	-20.71%	1.45%	-24.57%	135.83%
Enterprise Value	77.65	179.67	130.67	142.77	138.93	183.03
Last Close Price	0.61	3.06	4.00	6.00	7.56	11.80
Forward PE	-	2.14	2.14	2.14	-	-
PS Ratio	-	1288.86	158.63	154.42	379.06	193.28
PB Ratio	-1.11	-3.06	-5.80	-66.17	-178.47	1651.17
P/TBV Ratio	-	-	-	-	-	1602.14
EV/Sales Ratio	-	1703.00	183.49	154.73	374.97	190.01
Debt / Equity Ratio	-1.22	-1.07	-1.03	-8.76	-9.91	67.36
Net Debt / Equity Ratio	-1.04	-0.98	-0.91	-0.13	1.93	-27.99
Net Debt / EBITDA Ratio	-2.52	-2.48	-0.63	-0.01	0.07	0.18
Net Debt / FCF Ratio	-2.30	-2.15	-0.59	-0.01	0.06	0.18
Asset Turnover	-	0.01	0.04	0.05	0.03	0.08
Inventory Turnover	-	0.01	0.07	0.09	0.04	0.13
Quick Ratio	0.16	0.09	0.22	1.37	1.54	2.06
Current Ratio	0.20	0.12	0.32	1.52	1.80	2.25
Return on Equity (ROE)	124.12%	139.88%	301.26%	2092.61%	7005.80%	-3678.89%
Return on Assets (ROA)	-141.12%	-182.97%	-162.10%	-139.71%	-159.04%	-152.09%
Return on Invested Capital (ROIC)	-	-	-3871.34%	-309.22%	-1026.39%	-
Return on Capital Employed (ROCE)	42.57%	69.25%	-3815.90%	-305.34%	-286.75%	-289.36%
Buyback Yield / Dilution	-54.42%	-37.26%	-17.59%	-25.02%	-18.96%	-24.51%
Total Shareholder Return	-54.42%	-37.26%	-17.59%	-25.02%	-18.96%	-24.51%